Oramed Pharmaceuticals In...

NASDAQ: ORMP · Real-Time Price · USD
2.19
0.04 (1.86%)
At close: May 23, 2025, 9:37 AM
1.86%
Bid 2.01
Market Cap 89.46M
Revenue (ttm) n/a
Net Income (ttm) 4.46M
EPS (ttm) -0.71
PE Ratio (ttm) -3.08
Forward PE -1.68
Analyst n/a
Ask 2.29
Volume 1,040
Avg. Volume (20D) 89,411
Open 2.14
Previous Close 2.15
Day's Range 2.14 - 2.19
52-Week Range 1.82 - 3.09
Beta 1.65

About ORMP

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORMP
Website n/a
Full Company Profile

Earnings Surprise

Oramed Pharmaceuticals has released their quartely earnings on May 15, 2025:
  • Revenue of $2M exceeds estimates by $1.5M, with Infinity% YoY growth.
  • EPS of -0.19 misses estimates by -0.14, with -575.00% YoY decline.
  • Next Earnings Release

    Oramed Pharmaceuticals Inc. is scheduled to release its earnings on May 30, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    3 months ago
    +19.82%
    Oramed Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription
    11 months ago
    +14.73%
    Oramed Pharmaceuticals shares are trading higher after the company announced a $20 million buyback program and finalized its joint venture with Hefei Tianhui Biotech.